PMC:7324763 / 72982-73115 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T1167","span":{"begin":0,"end":4},"obj":"PR:000009196"},{"id":"T1168","span":{"begin":7,"end":17},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T1169","span":{"begin":80,"end":88},"obj":"SP_7"},{"id":"T1170","span":{"begin":107,"end":118},"obj":"DG_41"},{"id":"T91493","span":{"begin":0,"end":4},"obj":"PR:000009196"},{"id":"T58584","span":{"begin":7,"end":17},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T50670","span":{"begin":80,"end":88},"obj":"SP_7"},{"id":"T22229","span":{"begin":107,"end":118},"obj":"DG_41"}],"text":"Jak1/2 inhibitors (JAKi) are also undergoing clinical trials in moderate-severe COVID-19 patients, such as baricitinib (NCT04320277)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T503","span":{"begin":80,"end":88},"obj":"Disease"}],"attributes":[{"id":"A503","pred":"mondo_id","subj":"T503","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Jak1/2 inhibitors (JAKi) are also undergoing clinical trials in moderate-severe COVID-19 patients, such as baricitinib (NCT04320277)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T4327","span":{"begin":7,"end":17},"obj":"Chemical"}],"attributes":[{"id":"A59947","pred":"chebi_id","subj":"T4327","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"Jak1/2 inhibitors (JAKi) are also undergoing clinical trials in moderate-severe COVID-19 patients, such as baricitinib (NCT04320277)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2037","span":{"begin":0,"end":6},"obj":"Gene"},{"id":"2039","span":{"begin":89,"end":97},"obj":"Species"},{"id":"2042","span":{"begin":107,"end":118},"obj":"Chemical"},{"id":"2044","span":{"begin":80,"end":88},"obj":"Disease"}],"attributes":[{"id":"A2037","pred":"tao:has_database_id","subj":"2037","obj":"Gene:3716"},{"id":"A2039","pred":"tao:has_database_id","subj":"2039","obj":"Tax:9606"},{"id":"A2042","pred":"tao:has_database_id","subj":"2042","obj":"MESH:C000596027"},{"id":"A2044","pred":"tao:has_database_id","subj":"2044","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Jak1/2 inhibitors (JAKi) are also undergoing clinical trials in moderate-severe COVID-19 patients, such as baricitinib (NCT04320277)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T440","span":{"begin":0,"end":133},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Jak1/2 inhibitors (JAKi) are also undergoing clinical trials in moderate-severe COVID-19 patients, such as baricitinib (NCT04320277)."}